Sodium 2-benzamidoacetate, 95+%, 250g

Methyl-(2,2,2-trifluoro-ethyl)-amine hydrochloride, 95.0%, 10g

Ethyl 6-bromo-2-methylquinoline-3-carboxylate, 97%, 250mg

E-Plan phase EPLPH 20x/0.40 objective. Working distance 1.85 mm

Ethyl 3-cyclopropyl-3-oxopropionate, 97.00%, 1g

4-Methyl-3,4-dihydro-2H-pyrido[3,2-b][1,4]oxazine-7-carboxylic acid, 95.0%, 100mg

(Z)-Tetradec-11-en-1-ol, 97%, 1g

tert-Butyl 4-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperazine-1-carboxylate, 95.0%, 10g

1,6-Anhydro-beta-D-glucose>99.0%(GC)1g

(3r,4r)-3-Methylpiperidin-4-ol, 98%, 100mg

5,7-Dichloro-3-iodopyrazolo[1,5-a]pyrimidine, 98%, 1g

2,3-Dimethyl-1H-indole-5-carboxylic acid, 95.0%, 1g

1H-Indole-3-carbaldehyde, 99.00%, 25g